{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:50:53Z","timestamp":1792673453052,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T00:00:00Z","timestamp":1525305600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1038\/s41386-018-0080-2","type":"journal-article","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T10:17:52Z","timestamp":1525342672000},"page":"2361-2372","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["The L-type calcium channel blocker, isradipine, attenuates cue-induced cocaine-seeking by enhancing dopaminergic activity in the ventral tegmental area to nucleus accumbens pathway"],"prefix":"10.1038","volume":"43","author":[{"given":"Nii A.","family":"Addy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon M.","family":"Hughley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keri M.","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Baracz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua L.","family":"Haight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali M.","family":"Rajadhyaksha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,3]]},"reference":[{"issue":"7A-8A","key":"80_CR1","first-page":"957","volume":"25","author":"DJ Rohsenow","year":"1990","unstructured":"Rohsenow DJ, Niaura RS, Childress AR, Abrams DB, Monti PM. Cue reactivity in addictive behaviors: theoretical and treatment implications. Int J Addict. 1990;25(7A-8A):957\u201393.","journal-title":"Int J Addict"},{"key":"80_CR2","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.conb.2013.05.001","volume":"23","author":"R Sinha","year":"2013","unstructured":"Sinha R. The clinical neurobiology of drug craving. Curr Opin Neurobiol. 2013;23:649\u201354.","journal-title":"Curr Opin Neurobiol"},{"key":"80_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.pharmthera.2009.06.014","volume":"124","author":"N Yahyavi-Firouz-Abadi","year":"2009","unstructured":"Yahyavi-Firouz-Abadi N, See RE. Anti-relapse medications: preclinical models for drug addiction treatment. Pharmacol Ther. 2009;124:235\u201347.","journal-title":"Pharmacol Ther"},{"key":"80_CR4","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s13311-017-0532-0","volume":"14","author":"ZD Kabir","year":"2017","unstructured":"Kabir ZD, Martinez-Rivera A, Rajadhyaksha AM. From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms. Neurotheraphy. 2017;14:588\u2013613.","journal-title":"Neurotheraphy"},{"key":"80_CR5","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/mp.2017.9","volume":"22","author":"A Martinez-Rivera","year":"2017","unstructured":"Martinez-Rivera A, Hao J, Tropea TF, Giordano TP, Kosovsky M, Lee A, et al. Enhancing VTA Cav1.3 L-type Ca2+channel activity promotes cocaine and mood -related behaviors via overlapping AMPA receptor mechanisms in the nucleus accumbens. Mol Psychiatry. 2017;22:1735\u201345.","journal-title":"Mol Psychiatry"},{"key":"80_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/19336950.2015.1048936","volume":"10","author":"NJ Ortner","year":"2016","unstructured":"Ortner NJ, Striessnig J. L-type calcium channels as drug targets in CNS disorders. Channels. 2016;10:7\u201313.","journal-title":"Channels"},{"key":"80_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s002130000518","volume":"152","author":"SC Licata","year":"2000","unstructured":"Licata SC, Freeman AY, Pierce-Bancroft AF, Pierce RC. Repeated stimulation of L-type calcium channels in the rat ventral tegmental area mimics the initiation of behavioral sensitization to cocaine. Psychopharmacology. 2000;152:110\u20138.","journal-title":"Psychopharmacology"},{"key":"80_CR8","doi-asserted-by":"publisher","first-page":"13562","DOI":"10.1523\/JNEUROSCI.2315-11.2011","volume":"31","author":"K Schierberl","year":"2011","unstructured":"Schierberl K, Hao J, Tropea TF, Ra S, Giordano TP, Xu Q, et al. Cav1.2 L-type Ca(2)(+) channels mediate cocaine-induced GluA1 trafficking in the nucleus accumbens, a long-term adaptation dependent on ventral tegmental area Ca(v)1.3 channels. J Neurosci. 2011;31:13562\u201375.","journal-title":"J Neurosci"},{"key":"80_CR9","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/mp.2015.84","volume":"21","author":"M Degoulet","year":"2015","unstructured":"Degoulet M, Stelly CE, Ahn KC, Morikawa H. L-type Ca channel blockade with antihypertensive medication disrupts VTA synaptic plasticity and drug-associated contextual memory. Mol Psychiatry. 2015;21:394\u2013402.","journal-title":"Mol Psychiatry"},{"key":"80_CR10","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/nature01476","volume":"422","author":"PE Phillips","year":"2003","unstructured":"Phillips PE, Stuber GD, Heien ML, Wightman RM, Carelli RM. Subsecond dopamine release promotes cocaine seeking. Nature. 2003;422:614\u20138.","journal-title":"Nature"},{"key":"80_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.neuropharm.2013.07.001","volume":"75C","author":"W Solecki","year":"2013","unstructured":"Solecki W, Wickham RJ, Behrens S, Wang J, Zwerling B, Mason GF, et al. Differential role of ventral tegmental area acetylcholine and N-methyl-d-aspartate receptors in cocaine-seeking. Neuropharmacology. 2013;75C:9\u201318.","journal-title":"Neuropharmacology"},{"key":"80_CR12","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.neuron.2005.04.036","volume":"46","author":"GD Stuber","year":"2005","unstructured":"Stuber GD, Wightman RM, Carelli RM. Extinction of cocaine self-administration reveals functionally and temporally distinct dopaminergic signals in the nucleus accumbens. Neuron. 2005;46:661\u20139.","journal-title":"Neuron"},{"key":"80_CR13","doi-asserted-by":"publisher","first-page":"8594","DOI":"10.1074\/jbc.M610230200","volume":"282","author":"Y Liu","year":"2007","unstructured":"Liu Y, Dore J, Chen X. Calcium influx through L-type channels generates protein kinase M to induce burst firing of dopamine cells in the rat ventral tegmental area. J Biol Chem. 2007;282:8594\u2013603.","journal-title":"J Biol Chem"},{"key":"80_CR14","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1152\/jn.00757.2013","volume":"112","author":"Y Liu","year":"2014","unstructured":"Liu Y, Harding M, Pittman A, Dore J, Striessnig J, Rajadhyaksha A, et al. Cav1.2 and Cav1.3 L-type calcium channels regulate dopaminergic firing activity in the mouse ventral tegmental area. J Neurophysiol. 2014;112:1119\u201330.","journal-title":"J Neurophysiol"},{"key":"80_CR15","doi-asserted-by":"publisher","first-page":"6693","DOI":"10.1523\/JNEUROSCI.18-17-06693.1998","volume":"18","author":"A Bonci","year":"1998","unstructured":"Bonci A, Grillner P, Mercuri NB, Bernardi G. L-Type calcium channels mediate a slow excitatory synaptic transmission in rat midbrain dopaminergic neurons. J Neurosci. 1998;18:6693\u2013703.","journal-title":"J Neurosci"},{"key":"80_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/bs.pbr.2015.08.004","volume":"224","author":"M Venniro","year":"2016","unstructured":"Venniro M, Caprioli D, Shaham Y. Animal models of drug relapse and craving: From drug priming-induced reinstatement to incubation of craving after voluntary abstinence. Prog Brain Res. 2016;224:25\u201352.","journal-title":"Prog Brain Res"},{"key":"80_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00213-013-3082-0","volume":"229","author":"R Wickham","year":"2013","unstructured":"Wickham R, Solecki W, Rathbun L, McIntosh JM, Addy NA. Ventral tegmental area alpha6beta2 nicotinic acetylcholine receptors modulate phasic dopamine release in the nucleus accumbens core. Psychopharmacology. 2013;229:73\u201382.","journal-title":"Psychopharmacology"},{"key":"80_CR18","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0306-4522(02)00267-1","volume":"114","author":"BI Hyland","year":"2002","unstructured":"Hyland BI, Reynolds JN, Hay J, Perk CG, Miller R. Firing modes of midbrain dopamine cells in the freely moving rat. Neuroscience. 2002;114:475\u201392.","journal-title":"Neuroscience"},{"key":"80_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1152\/jn.00269.2013","volume":"111","author":"JL Koranda","year":"2014","unstructured":"Koranda JL, Cone JJ, McGehee DS, Roitman MF, Beeler JA, Zhuang X. Nicotinic receptors regulate the dynamic range of dopamine release in vivo. J Neurophysiol. 2014;111:103\u201311.","journal-title":"J Neurophysiol"},{"key":"80_CR20","doi-asserted-by":"publisher","first-page":"13989","DOI":"10.1523\/JNEUROSCI.0450-13.2013","volume":"33","author":"BT Saunders","year":"2013","unstructured":"Saunders BT, Yager LM, Robinson TE. Cue-evoked cocaine \u201ccraving\u201d: role of dopamine in the accumbens core. J Neurosci. 2013;33:13989\u20134000.","journal-title":"J Neurosci"},{"key":"80_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00213-006-0611-0","volume":"190","author":"M Reimold","year":"2007","unstructured":"Reimold M, Solbach C, Noda S, Schaefer JE, Bartels M, Beneke M, et al. Occupancy of dopamine D(1), D (2) and serotonin (2A) receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol. Psychopharmacology. 2007;190:241\u20139.","journal-title":"Psychopharmacology"},{"key":"80_CR22","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/S0028-3908(99)00039-8","volume":"38","author":"ZL Rossetti","year":"1999","unstructured":"Rossetti ZL, Isola D, De Vry J, Fadda F. Effects of nimodipine on extracellular dopamine levels in the rat nucleus accumbens in ethanol withdrawal. Neuropharmacology. 1999;38:1361\u20139.","journal-title":"Neuropharmacology"},{"key":"80_CR23","doi-asserted-by":"publisher","first-page":"7464","DOI":"10.1523\/JNEUROSCI.0612-04.2004","volume":"24","author":"A Rajadhyaksha","year":"2004","unstructured":"Rajadhyaksha A, Husson I, Satpute SS, Kuppenbender KD, Ren JQ, Guerriero RM, et al. L-type Ca2\u2009+\u2009channels mediate adaptation of extracellular signal-regulated kinase 1\/2 phosphorylation in the ventral tegmental area after chronic amphetamine treatment. J Neurosci. 2004;24:7464\u201376.","journal-title":"J Neurosci"},{"key":"80_CR24","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.neuroscience.2013.10.037","volume":"256","author":"S Recillas-Morales","year":"2014","unstructured":"Recillas-Morales S, Sanchez-Vega L, Ochoa-Sanchez N, Caballero-Floran I, Paz-Bermudez F, Silva I, et al. L-type Ca(2)(+) channel activity determines modulation of GABA release by dopamine in the substantia nigra reticulata and the globus pallidus of the rat. Neuroscience. 2014;256:292\u2013301.","journal-title":"Neuroscience"},{"key":"80_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/syn.890090109","volume":"9","author":"LH Parsons","year":"1991","unstructured":"Parsons LH, Smith AD, Justice JB Jr.. Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine. Synapse. 1991;9:60\u20135.","journal-title":"Synapse"},{"key":"80_CR26","first-page":"95","volume":"1","author":"K Blum","year":"2015","unstructured":"Blum K, Thanos PK, Oscar-Berman M, Febo M, Baron D, Badgaiyan RD, et al. Dopamine in the Brain: hypothesizing Surfeit or Deficit Links to Reward and Addiction. J Reward Defic Syndr. 2015;1:95\u2013104.","journal-title":"J Reward Defic Syndr"},{"key":"80_CR27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0014-2999(92)90706-A","volume":"221","author":"ZL Rossetti","year":"1992","unstructured":"Rossetti ZL, Hmaidan Y, Gessa GL. Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur J Pharmacol. 1992;221:227\u201334.","journal-title":"Eur J Pharmacol"},{"key":"80_CR28","doi-asserted-by":"publisher","first-page":"924","DOI":"10.3389\/fphar.2017.00924","volume":"8","author":"A Hasbi","year":"2017","unstructured":"Hasbi A, Perreault ML, Shen MYF, Fan T, Nguyen T, Alijaniaram M, et al. Activation of Dopamine D1-D2 Receptor Complex Attenuates Cocaine Reward and Reinstatement of Cocaine-Seeking through Inhibition of DARPP-32, ERK, and DeltaFosB. Front Pharmacol. 2017;8:924.","journal-title":"Front Pharmacol"},{"key":"80_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/02791072.1999.10471733","volume":"31","author":"R Malcolm","year":"1999","unstructured":"Malcolm R, Brady KT, Moore J, Kajdasz D. Amlodipine treatment of cocaine dependence. J Psychoact Drugs. 1999;31:117\u201320.","journal-title":"J Psychoact Drugs"},{"key":"80_CR30","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/00002826-199408000-00007","volume":"17","author":"RB Rosse","year":"1994","unstructured":"Rosse RB, Alim TN, Fay-McCarthy M, Collins JP Jr., Vocci FJ Jr., Lindquist T, et al. Nimodipine pharmacotherapeutic adjuvant therapy for inpatient treatment of cocaine dependence. Clin Neuropharmacol. 1994;17:348\u201358.","journal-title":"Clin Neuropharmacol"},{"key":"80_CR31","doi-asserted-by":"publisher","first-page":"4401","DOI":"10.1007\/s00213-015-4061-4","volume":"232","author":"JJ Cunningham","year":"2015","unstructured":"Cunningham JJ, Orr E, Lothian BC, Morgen J, Brebner K. Effects of fendiline on cocaine-seeking behavior in the rat. Psychopharmacology. 2015;232:4401\u201310.","journal-title":"Psychopharmacology"},{"key":"80_CR32","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0091-3057(03)00157-6","volume":"75","author":"M Sofuoglu","year":"2003","unstructured":"Sofuoglu M, Singha A, Kosten TR, McCance-Katz FE, Petrakis I, Oliveto A. Effects of naltrexone and isradipine, alone or in combination, on cocaine responses in humans. Pharmacol Biochem Behav. 2003;75:801\u20138.","journal-title":"Pharmacol Biochem Behav"},{"key":"80_CR33","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/01.jcp.0000115662.45074.c3","volume":"24","author":"BA Johnson","year":"2004","unstructured":"Johnson BA, Roache JD, Ait-Daoud N, Wells LT, Mauldin JB. Effects of isradipine on cocaine-induced subjective mood. J Clin Psychopharmacol. 2004;24:180\u201391.","journal-title":"J Clin Psychopharmacol"},{"key":"80_CR34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1037\/1064-1297.13.4.319","volume":"13","author":"JD Roache","year":"2005","unstructured":"Roache JD, Johnson BA, Ait-Daoud N, Mauldin JB, Thornton JE, Wells LT, et al. Effects of repeated-dose isradipine on the abuse liability of cocaine. Exp Clin Psychopharmacol. 2005;13:319\u201326.","journal-title":"Exp Clin Psychopharmacol"},{"key":"80_CR35","first-page":"1295","volume":"12","author":"RG Williams","year":"1996","unstructured":"Williams RG, Kavanagh KM, Teo KK. Pathophysiology and treatment of cocaine toxicity: implications for the heart and cardiovascular system. Can J Cardiol. 1996;12:1295\u2013301.","journal-title":"Can J Cardiol"},{"key":"80_CR36","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s002130050575","volume":"136","author":"B Johnson","year":"1998","unstructured":"Johnson B, Barron B, Fang B, Lamki L, Wagner L, Wells L, et al. Isradipine prevents global and regional cocaine-induced changes in brain blood flow: a preliminary study. Psychopharmacology. 1998;136:335\u201341.","journal-title":"Psychopharmacology"},{"key":"80_CR37","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.amjhyper.2005.01.020","volume":"18","author":"BA Johnson","year":"2005","unstructured":"Johnson BA, Wells LT, Roache JD, Wallace C, Ait-Daoud N, Wang Y. Isradipine decreases the hemodynamic response of cocaine and methamphetamine results from two human laboratory studies: results from two human laboratory studies. Am J Hypertens. 2005;18:813\u201322.","journal-title":"Am J Hypertens"},{"issue":"10 Pt 2","key":"80_CR38","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1016\/j.neubiorev.2013.10.002","volume":"37","author":"AB Konova","year":"2013","unstructured":"Konova AB, Moeller SJ, Goldstein RZ. Common and distinct neural targets of treatment: changing brain function in substance addiction. Neurosci Biobehav Rev. 2013;37(10 Pt 2):2806\u201317.","journal-title":"Neurosci Biobehav Rev"},{"key":"80_CR39","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/09595230801927372","volume":"27","author":"J Shearer","year":"2008","unstructured":"Shearer J. The principles of agonist pharmacotherapy for psychostimulant dependence. Drug Alcohol Rev. 2008;27:301\u20138.","journal-title":"Drug Alcohol Rev"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41386-018-0080-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-018-0080-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-018-0080-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:03:03Z","timestamp":1684616583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-018-0080-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,3]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["80"],"URL":"https:\/\/doi.org\/10.1038\/s41386-018-0080-2","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,3]]},"assertion":[{"value":"12 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}